Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer

Withdrawn before enrolling · Phase 1

Conditions studied: Prostate Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Randomized phase I trial to determine the effectiveness of genistein in treating patients who have stage II, stage III, or stage IV prostate cancer.

Key facts

Study ID

NCT00005827

Run by

UNC Lineberger Comprehensive Cancer Center

People needed

0

Starts

1999-12-01

Expected to finish

2003-05-01

Last updated by the study team

2012-04-24

Who can join

Age: 40 and older. Sex: male. Healthy volunteers: not accepted.

Where it is running

• Lineberger Comprehensive Cancer Center, UNC — Chapel Hill, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.